|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-2-13
|
|
pubmed:abstractText |
Monitoring of serum free immunoglobulin light chains (FLC) in 26 myeloma patients who achieved immunofixation negativity after allografting showed a decrease of FLC at a median of 128 days before immunofixation negativity. In patients who subsequently relapsed, a 25% increase of FLC was observed at a median of 98 days before immunofixation positivity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1592-8721
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
275-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17296589-Adult,
pubmed-meshheading:17296589-Binding Sites,
pubmed-meshheading:17296589-Female,
pubmed-meshheading:17296589-Follow-Up Studies,
pubmed-meshheading:17296589-Humans,
pubmed-meshheading:17296589-Immunoglobulin Light Chains,
pubmed-meshheading:17296589-Male,
pubmed-meshheading:17296589-Middle Aged,
pubmed-meshheading:17296589-Multiple Myeloma,
pubmed-meshheading:17296589-Remission Induction,
pubmed-meshheading:17296589-Stem Cell Transplantation,
pubmed-meshheading:17296589-Time Factors,
pubmed-meshheading:17296589-Treatment Outcome,
pubmed-meshheading:17296589-Tumor Markers, Biological
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.
|
|
pubmed:publicationType |
Letter,
Research Support, Non-U.S. Gov't
|
